Answers are grounded in this paper and cite their sources.
(1994). Overview Oncologic, Endocrine & Metabolic: Recent advances in angiogenesis inhibitors. Expert Opinion on Therapeutic Patents: Vol. 4, No. 6, pp. 641-654.
No takes yet. Share an insight, caveat, or question.
Herblin et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: